Pharmacological Targets for Correction of Dyslipidemias. Opportunities and Prospects of Therapeutic Use


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

The review summarizes literature data on existing pharmacological agents and novel drug preparations developed for correction of dyslipidemias and molecular mechanisms of their action. Much attention is paid to analysis of experimental and clinical studies aimed at identification of new pharmacological targets for correction of dyslipidemias and characterization of approaches increasing high density lipoproteins functionality. The implementation of alternative pharmacological agents with new alternative mechanisms of action may improve the effectiveness of traditional treatment in the future.

作者简介

V. Kudinov

Institute of Biomedical Chemistry (IBMC)

Email: tz-post@list.ru
俄罗斯联邦, ul. Pogodinskaya 10, Moscow, 119121

T. Zakharova

Institute of Biomedical Chemistry (IBMC)

编辑信件的主要联系方式.
Email: tz-post@list.ru
俄罗斯联邦, ul. Pogodinskaya 10, Moscow, 119121

T. Torkhovskaya

Institute of Biomedical Chemistry (IBMC)

Email: tz-post@list.ru
俄罗斯联邦, ul. Pogodinskaya 10, Moscow, 119121

O. Ipatova

Institute of Biomedical Chemistry (IBMC)

Email: tz-post@list.ru
俄罗斯联邦, ul. Pogodinskaya 10, Moscow, 119121

A. Archakov

Institute of Biomedical Chemistry (IBMC)

Email: tz-post@list.ru
俄罗斯联邦, ul. Pogodinskaya 10, Moscow, 119121

补充文件

附件文件
动作
1. JATS XML

版权所有 © Pleiades Publishing, Ltd., 2018